XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Notes Details
Uncategorized
- Pay vs Performance Disclosure
- Insider Trading Arrangements

Royalty and Commercial Payment Purchase Agreements - Talphera (Details)

v3.24.1.u1

Royalty and Commercial Payment Purchase Agreements - Talphera (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
	Jan. 12, 2024	Apr. 30, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Agreements
Payments of consideration under RPAs, AAAs and CPPAs			$ 15,000	$ 9,600
Receipts under RPAs, AAAs and CPPAs			7,771	$ 2,366
Short-term royalty and commercial payment receivables			9,819		$ 14,215
Talphera \| Commercial Payment Purchase Agreement
Agreements
Threshold amount for royalties and milestones	$ 20,000
Payments of consideration under RPAs, AAAs and CPPAs	$ 8,000
Receipts under RPAs, AAAs and CPPAs			25
Short-term royalty and commercial payment receivables			0
Amount of allowance for credit losses			$ 0
Talphera \| Commercial Payment Purchase Agreement \| All customers excluding DoD
Agreements
Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive (as a percent)	100.00%
Royalty percentage entity has the right to fully retain	15.00%
Talphera \| Commercial Payment Purchase Agreement \| DoD
Agreements
Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive (as a percent)	100.00%
Royalties shared equally with counterparty (as a percent)	75.00%
Talphera \| Alora Pharmaceuticals \| Asset Purchase Agreement and Marketing Agreement
Agreements
Maximum milestone payments entitled to receive		$ 116,500
Talphera \| Alora Pharmaceuticals \| Asset Purchase Agreement and Marketing Agreement \| All customers excluding DoD
Agreements
Royalties entity has right to receive (as a percent)	15.00%	15.00%
Talphera \| Alora Pharmaceuticals \| Asset Purchase Agreement and Marketing Agreement \| DoD
Agreements
Royalties entity has right to receive (as a percent)	75.00%	75.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479344/326-20-45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479837/606-10-45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479319/326-20-50-13

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479319/326-20-50-13

+ Details

Name:	us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Maximum eligible milestone payments receivable upon achievement of milestones. May include, but not limited to, development, regulatory, commercial, sales-based and clinical milestones.

+ References

No definition available.

+ Details

Name:	xoma_EligibleMilestonePaymentsReceivableUponAchievementOfMilestones
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments.

+ References

No definition available.

+ Details

Name:	xoma_PaymentOfConsiderationUnderAgreementsInvestingActivities
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash inflow under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), and Commercial Payment Purchase Agreements (CPPAs), classified as investing activities. Receipts may represent commercial payments attributable to net sales.

+ References

No definition available.

+ Details

Name:	xoma_ReceiptsUnderAgreementsInvestingActivities
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalty and commercial payment receivables probable and reasonably estimable to be received within one year or the normal operating cycle, if longer.

+ References

No definition available.

+ Details

Name:	xoma_RightsReceivableCurrent
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Threshold amount for royalties and milestones for determining amount entity has the right to receive.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyAndMilestonesReceivableThreshold
Namespace Prefix:	xoma_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Royalties entity has the right to receive as a percentage of net sales.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyReceivablePercentageOnNetSales
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalties and milestones entity has the right to receive as a percentage counterparty is entitled to receive, up to specified threshold.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyReceivablePercentageOnNetSalesAndPercentageOfMilestones
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalty percentage entity has the right to fully retain which counterparty is entitled to receive upon reaching specified threshold.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyReceivablePercentageOnNetSalesFullyRetained
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalties entity has the right to receive as a percentage shared with counterparty upon reaching threshold.

+ References

No definition available.

+ Details

Name:	xoma_RoyaltyReceivablePercentageOnNetSalesSharedWithCounterparty
Namespace Prefix:	xoma_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=xoma_TalpheraMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=xoma_CommercialPaymentPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=xoma_AllCustomersExcludingU.s.DepartmentOfDefenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=xoma_U.s.DepartmentOfDefenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=xoma_TalpheraMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=xoma_AloraPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=xoma_AssetPurchaseAgreementAndMarketingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: